Health
New gene-based vaccine strategy receives grant from the Bill & Melinda Gates Foundation – News-Medical.Net
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million…
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation.
The grant will aid the effort to bring further preclinical validation to the AAV vaccine platform. An AAVCOVID vaccine candidate is set to enter clinical trials in 2021.
The AAVCOVID vaccine program was founded at Mass General Brigham at the outset of the pandemic.
Preliminary tests of the vaccines’…
-
Noosa News23 hours agoQueensland government moves censure motion, condemns opposition absences from parliament
-
Noosa News20 hours agoFamily of slain mum seek urgent entry to Australia to care for her sons
-
General23 hours agoPricier supermarkets sour on grocery cost survey
-
General15 hours agoLive updates: Australia vs West Indies, first Test, day one at Kensington Oval in Bridgetown